KYVERNA THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Kyverna Therapeutics, Inc. - KYTX
Portfolio Pulse from
Kahn Swick & Foti, LLC has issued a reminder to investors of Kyverna Therapeutics, Inc. about the lead plaintiff deadline for a class action lawsuit. The lawsuit pertains to losses from shares purchased during the company's February 2024 IPO.
December 18, 2024 | 4:00 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Kyverna Therapeutics is facing a class action lawsuit related to its February 2024 IPO. Investors with significant losses are reminded of the lead plaintiff deadline.
The class action lawsuit could negatively impact Kyverna's stock price as it may lead to financial liabilities and damage investor confidence. The reminder of the lead plaintiff deadline highlights the seriousness of the legal issue.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100